丛集性头痛长期缓解与自然病程:基于访谈的队列研究
该横断面队列研究纳入莱顿大学医学中心625例丛集性头痛患者,通过电话访谈识别长期缓解者(无预防治疗且无发作≥5年或平均发作间期两倍)。125例(20%)达到长期缓解,平均缓解年龄55岁,病程23年,62%为突然缓解;发作性丛集性头痛、戒烟、较高发作强度和较大发病年龄与缓解概率较高相关。
要点
- 长期缓解平均发生在55岁,病程约23年,62%为突然缓解。
- 发作性丛集性头痛、戒烟、较高发作强度和较大发病年龄与缓解概率较高相关。
- 长期缓解不依赖于单一因素如病程,缓解年龄无峰值,病程个体差异大。
核心结论
- 长期缓解通常始于55岁左右,病程约25年,发作性形式缓解概率高于慢性形式。
- 戒烟与长期缓解相关,支持吸烟与疾病活动的因果联系。
研究设计与样本
- 横断面队列研究,邀请莱顿大学医学中心队列中1801例有(可能)丛集性头痛史者完成筛查,625例纳入分析。
- 长期缓解定义为无当前预防治疗且无发作≥5年和/或平均发作间期两倍。
主要发现
- 778/1801(43.2%)应答,625例纳入调查分析,125例(20%)符合长期缓解标准。
- 纳入时中位年龄58岁(IQR 48-67),女性占32%。
- 长期缓解平均年龄55岁(IQR 48-63),病程23年(IQR 15-33)。
- 62%(78例)为突然缓解;38%(47例)为逐渐缓解,其中发作频率下降65%、强度下降59%、发作间期延长52%。
- 发作性丛集性头痛(HR 6.60,95%CI 3.55-12.31)、戒烟(HR 2.53,95%CI 1.66-3.86)、较高发作强度(HR 1.28,95%CI 1.08-1.52)和较大发病年龄(HR 1.05,95%CI 1.03-1.06)与长期缓解概率较高相关。
关键数值与推荐
- 长期缓解定义:无当前预防治疗且无发作≥5年和/或平均发作间期两倍。
- 主要结局为长期缓解平均发病年龄和病程。
临床怎么用
- 临床可告知患者长期缓解平均在55岁左右出现,病程约23年,但个体差异大。
- 戒烟可能提高长期缓解概率,应作为患者管理建议。
- 发作性形式患者缓解概率更高,尽管病程可能更长。
局限性
- 回顾性研究结果需未来研究确认。
- 横断面设计可能影响因果推断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: The aim of this study was to gain rare insight into prolonged cluster headache (CH) remission by (1) identifying patterns and factors associated with and (2) phenotypical changes before prolonged remission. The results can help patients better understand their disease course and uncover mechanisms behind spontaneous remission. METHODS: In this cross-sectional cohort study, all participants with a history of (probable) CH from the Leiden University Medical Center cohort were invited to complete a screening survey. Participants in prolonged remission were invited for a telephone interview. Prolonged remission was defined as (1) no current prophylactic treatment and (2) an attack-free period of ≥5 years and/or twice the mean between-episode time. Main outcomes are average age at prolonged remission onset and disease duration. Data were collected between April 10 and August 9, 2024, and analyzed using descriptive and survival statistics. RESULTS: Of those invited, 43.2% (778/1,801) responded; 625 were included in the survey analysis, and 125 (20%) met prolonged remission criteria during interview. The median age at inclusion was 58 years (interquartile range [IQR] 48-67) with 32% female. Remission occurred on average at age 55 (IQR 48-63) after a disease duration of 23 (15-33) years. In 62% (N = 78), remission occurred abruptly. Of those with gradual remission (38%, N = 47), attack frequency (65%) and intensity (59%) decreased and between-episode intervals increased (52%) before remission. Probability of prolonged remission was higher in those with episodic CH (hazard ratio [HR] 6.60, 95% CI 3.55-12.31), who had quit smoking (HR 2.53, 95% CI 1.66-3.86), who had a higher attack intensity (HR 1.28, 95% CI 1.08-1.52), and who had a higher age at disease onset (HR 1.05, 95% CI 1.03-1.06). DISCUSSION: This cohort offers rare insight into prolonged CH remission, typically starting around the mid-50s after 25 years of active disease. Prolonged remission is not tied to a single factor such as disease duration. Remission onset does not peak at a specific age, and disease duration varies widely between patients with remission. Remission probability is higher in the episodic form despite a longer disease duration compared with the chronic form. The association between quitting smoking and prolonged remission supports a causal link with smoking and disease activity. These preliminary retrospective results require confirmation in future studies.
引用
- Naber W, van Tilborg P, Zuidgeest A, et al. Exploration of Prolonged Remission and the Natural Course of Cluster Headache: An Interview-Based Cohort Study. Neurology. 2025. PMID: 40513059. doi:10.1212/WNL.0000000000213795
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。